SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 1,600.56 |
| Book Value / Share | 21.00 |
| Price / Book | n/a |
| NCAV ($M) | -1,552.38 |
| NCAV / Share | -20.37 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.86 |
| Return on Assets (ROA) | 0.69 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.67 |
| Current Ratio | 2.79 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,526.76 |
| Assets | 4,679.70 |
| Liabilities | 3,079.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Marathon Asset Management Lp | 5.10 | ||
| 13G | Franklin Resources Inc |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| NAVB – Navidea Biopharmaceuticals, Inc. | NBIO – Nascent Biotech, Inc. |
| NBRVF – Nabriva Therapeutics plc | NEPTF – Neptune Wellness Solutions Inc. |
| NEXI – NexImmune, Inc. |
Financial data and stock pages provided by
Fintel.io